Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| macrophage | 29 studies | 40% ± 21% | |
| B cell | 26 studies | 34% ± 13% | |
| endothelial cell | 25 studies | 40% ± 19% | |
| non-classical monocyte | 23 studies | 54% ± 15% | |
| natural killer cell | 17 studies | 23% ± 5% | |
| naive B cell | 17 studies | 30% ± 10% | |
| oligodendrocyte precursor cell | 15 studies | 64% ± 20% | |
| microglial cell | 14 studies | 44% ± 14% | |
| oligodendrocyte | 13 studies | 39% ± 13% | |
| memory B cell | 13 studies | 26% ± 7% | |
| CD16-positive, CD56-dim natural killer cell, human | 12 studies | 25% ± 5% | |
| classical monocyte | 11 studies | 27% ± 8% | |
| GABAergic neuron | 11 studies | 59% ± 24% | |
| myeloid cell | 10 studies | 42% ± 19% | |
| glutamatergic neuron | 9 studies | 40% ± 19% | |
| capillary endothelial cell | 9 studies | 25% ± 7% | |
| pericyte | 9 studies | 32% ± 20% | |
| fibroblast | 9 studies | 27% ± 7% | |
| monocyte | 8 studies | 37% ± 14% | |
| smooth muscle cell | 8 studies | 23% ± 10% | |
| basal cell | 8 studies | 31% ± 14% | |
| ciliated cell | 8 studies | 23% ± 6% | |
| adipocyte | 8 studies | 26% ± 8% | |
| dendritic cell | 8 studies | 30% ± 10% | |
| neuron | 6 studies | 56% ± 25% | |
| epithelial cell | 6 studies | 33% ± 15% | |
| interneuron | 6 studies | 72% ± 15% | |
| retina horizontal cell | 6 studies | 31% ± 9% | |
| amacrine cell | 5 studies | 43% ± 15% | |
| cardiac muscle cell | 5 studies | 37% ± 7% | |
| mononuclear phagocyte | 5 studies | 36% ± 20% | |
| retinal cone cell | 5 studies | 31% ± 13% | |
| mast cell | 5 studies | 30% ± 13% | |
| endothelial cell of lymphatic vessel | 5 studies | 25% ± 9% | |
| type II pneumocyte | 5 studies | 25% ± 5% | |
| mature NK T cell | 4 studies | 21% ± 5% | |
| astrocyte | 4 studies | 29% ± 10% | |
| granule cell | 4 studies | 46% ± 19% | |
| precursor B cell | 4 studies | 34% ± 10% | |
| immature B cell | 4 studies | 41% ± 14% | |
| retinal pigment epithelial cell | 4 studies | 46% ± 15% | |
| hepatocyte | 4 studies | 67% ± 18% | |
| brush cell | 4 studies | 44% ± 18% | |
| ionocyte | 3 studies | 44% ± 8% | |
| glomerular endothelial cell | 3 studies | 44% ± 6% | |
| differentiation-committed oligodendrocyte precursor | 3 studies | 51% ± 6% | |
| GABAergic interneuron | 3 studies | 64% ± 3% | |
| megakaryocyte | 3 studies | 41% ± 17% | |
| mesothelial cell | 3 studies | 28% ± 7% | |
| vein endothelial cell | 3 studies | 17% ± 1% | |
| GABAergic amacrine cell | 3 studies | 42% ± 4% | |
| Mueller cell | 3 studies | 21% ± 1% | |
| glycinergic amacrine cell | 3 studies | 35% ± 5% | |
| endothelial cell of vascular tree | 3 studies | 29% ± 10% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 26% ± 5% | |
| podocyte | 3 studies | 73% ± 19% | |
| abnormal cell | 3 studies | 42% ± 21% | |
| enteroendocrine cell | 3 studies | 30% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| adrenal gland | 100% | 7507.06 | 258 / 258 | 100% | 26.94 | 229 / 230 |
| liver | 100% | 5859.19 | 226 / 226 | 100% | 32.00 | 404 / 406 |
| brain | 99% | 4025.53 | 2621 / 2642 | 100% | 33.05 | 702 / 705 |
| kidney | 100% | 4438.31 | 89 / 89 | 96% | 19.72 | 864 / 901 |
| breast | 99% | 3485.73 | 455 / 459 | 95% | 22.73 | 1062 / 1118 |
| pancreas | 96% | 2080.51 | 314 / 328 | 94% | 13.52 | 168 / 178 |
| prostate | 99% | 2126.43 | 242 / 245 | 88% | 7.09 | 441 / 502 |
| lung | 100% | 4043.81 | 576 / 578 | 86% | 16.91 | 989 / 1155 |
| esophagus | 100% | 4307.25 | 1442 / 1445 | 84% | 29.38 | 154 / 183 |
| bladder | 95% | 1864.95 | 20 / 21 | 85% | 17.65 | 426 / 504 |
| uterus | 92% | 1701.06 | 157 / 170 | 83% | 21.01 | 383 / 459 |
| thymus | 90% | 1476.10 | 587 / 653 | 77% | 8.85 | 464 / 605 |
| skin | 85% | 5021.35 | 1545 / 1809 | 76% | 14.04 | 358 / 472 |
| intestine | 94% | 1750.01 | 912 / 966 | 62% | 5.95 | 325 / 527 |
| stomach | 97% | 1570.80 | 349 / 359 | 56% | 6.18 | 161 / 286 |
| ovary | 89% | 2198.44 | 161 / 180 | 51% | 4.56 | 220 / 430 |
| spleen | 100% | 8584.09 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.59 | 1 / 1 |
| adipose | 100% | 5216.24 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| muscle | 100% | 3627.35 | 800 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 23.21 | 44 / 45 |
| heart | 95% | 2312.07 | 818 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 91% | 49.08 | 73 / 80 |
| blood vessel | 86% | 2050.23 | 1148 / 1335 | 0% | 0 | 0 / 0 |
| peripheral blood | 63% | 1166.23 | 585 / 929 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 62% | 6.83 | 18 / 29 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007169 | Biological process | cell surface receptor protein tyrosine kinase signaling pathway |
| GO_0061333 | Biological process | renal tubule morphogenesis |
| GO_0034334 | Biological process | adherens junction maintenance |
| GO_0071498 | Biological process | cellular response to fluid shear stress |
| GO_0032233 | Biological process | positive regulation of actin filament bundle assembly |
| GO_0007155 | Biological process | cell adhesion |
| GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
| GO_0030036 | Biological process | actin cytoskeleton organization |
| GO_0072160 | Biological process | nephron tubule epithelial cell differentiation |
| GO_0007009 | Biological process | plasma membrane organization |
| GO_0030035 | Biological process | microspike assembly |
| GO_2001013 | Biological process | epithelial cell proliferation involved in renal tubule morphogenesis |
| GO_0072102 | Biological process | glomerulus morphogenesis |
| GO_0001726 | Cellular component | ruffle |
| GO_0030139 | Cellular component | endocytic vesicle |
| GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
| GO_0015629 | Cellular component | actin cytoskeleton |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0003785 | Molecular function | actin monomer binding |
| GO_0005543 | Molecular function | phospholipid binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0005515 | Molecular function | protein binding |
| GO_0003779 | Molecular function | actin binding |
| Gene name | MTSS1 |
| Protein name | Protein MTSS 1 (Metastasis suppressor YGL-1) (Metastasis suppressor protein 1) (Missing in metastasis protein) MTSS1 protein MTSS I-BAR domain containing 1 |
| Synonyms | KIAA0429 MIM |
| Description | FUNCTION: May be related to cancer progression or tumor metastasis in a variety of organ sites, most likely through an interaction with the actin cytoskeleton. |
| Accessions | H0YAZ8 ENST00000325064.9 [O43312-5] ENST00000519168.5 O43312 A5YM41 ENST00000378017.7 [O43312-4] ENST00000522118.1 H0YBL3 E7EWW5 ENST00000522162.1 H0YB53 ENST00000523179.5 E5RJX3 ENST00000524090.5 ENST00000518547.6 [O43312-1] ENST00000431961.6 [O43312-2] |